The Industry Edge: Global Life Sciences Digest

Sidley Blogs

GoodLifeSci -
Perspectives for the Life Sciences Community

Subscribe Here

Sidley Awards & News

Awards

Sidley Recognized as Premier Life Sciences Firm in LMG Life Sciences 2022
News

Sidley Represents Walgreens Boots Alliance in Its US$1.37 Billion Acquisition of Shields Health Solutions
News

Sidley Represents LifePoint Health in Multi-Year Strategic Partnership with Google Cloud
News

James Lu Joins Sidley’s Growing Life Sciences, Corporate, and ECVC Practices
Awards

Sidley Awarded “Patent Impact Case of the Year” at LMG Life Sciences Americas Awards 2022
News

Sidley Represents MicroPort NeuroTech Limited in Successful Hong Kong IPO
Awards

Sidley Duo Named 2022 Private Equity "Leaders of Influence" by Los Angeles Business Journal
Awards

Sidley Wins Two “Firm of the Year” Awards at China Business Law Awards 2022
Awards

Sidley Receives High Praise in Chambers USA 2022
News

Sidley Secures Appellate Win for Client Nektar Therapeutics
Awards

Sidley Wins “Impact Case of the Year Award” at LMG Life Sciences Awards 2022 EMEA
News

Sidley Represents amika and Eva NYC Brands in Their Acquisition by Bansk Group
News

Sidley Represents Underwriters in Bausch + Lomb Dual-Listed IPO
News

Sidley Represents Myovant Sciences in Exclusive License Agreement with Accord Healthcare, Ltd. to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe
Awards

Sidley Shortlisted for Three Awards at LMG Life Sciences Awards EMEA
News

Sidley Represents Seller of TheraBreath Brand in US$580 Million Sale to Church & Dwight
Awards

Sidley Named “Crisis Management Team of the Year” at 2021 British Legal Awards
News

Sidley Represents Kiniciti on Its Investment in Ncardia
News

Sidley Advises IO Biotech in IPO
Awards

U.S. News – Best Lawyers Honors Sidley as “Law Firm of the Year” in FDA Law
News

Sidley Advised KKR on Its Investment in Biosynth Carbosynth
News

Sidley Represents Shanghai MicroPort MedBot (Group) Co., Ltd. in Successful Hong Kong IPO
Awards

Sidley Given Quintet of Awards by LMG Life Sciences Americas

In This Issue

Events

Life Sciences Regulatory Bootcamp
Regulatory Updates

Unprecedented Changes to Medicare Programs Leave Many Questions Unanswered for Pharmaceutical Manufacturers
Regulatory Updates

Oversight Tools Piloted During COVID-19 Pandemic Are Here to Stay: FDA Issues Draft Guidance on Remote Regulatory Assessments
Global Drug Pricing

Comment Period Now Open for Proposed Rule Implementing Manufacturer Refunds for Discarded Drugs
Events

Boston Life Sciences Roundtable
Regulatory Updates

FDA Releases Draft Guidance and Urges Industry to Address Concerns Regarding Non-Penicillin Beta-Lactam Drugs Cross-Contamination
Regulatory Updates

OIG Approves Manufacturer’s Arrangement to Make Zero-Interest Financing Available to Provider Customers
Events

Digital Health App'ero and Life Sciences College
Events

Bay Area Lifesciences Roundtable
Events

Regulatory Reboot: What You Need to Know About Biopharma Regulation in 2022 and Beyond
Digital Health

Digital Health Industry Take Note: New HIPAA Comment Opportunity and Guidance Addresses Growing Risk of Cybersecurity Attacks
Global Drug Pricing

Maine Enacts Canadian Reference Pricing Law
Regulatory Updates

OIG Approves Pharmaceutical Manufacturer-Sponsored Genetic Testing and Counseling Arrangement
Data Privacy

If Your Company Is GDPR Compliant, Are You Ready for China’s PIPL?
Regulatory Updates

Shortages of Medicinal Products Tackled by EU Regulators
Global Drug Pricing

U.S. Looks to Introduce European-Style Drug Price Controls
Regulatory Updates

Four Ways FDA’s New Intended Use Regulations Affect Drug and Medical Device Companies
Data Privacy

How To Minimize FCA Cyberfraud Enforcement Risk
Events

Webinar Series: How the Green Wave Is Set to Reshape Chemical and Consumer Product Regulations Globally
Global Drug Pricing

Global Drug Pricing Resource Page
Digital Health

Regulators Offer Fresh Guidance on Using Real-World Data to Support Regulatory Decisions
Events

FDA’s Intended Use Final Rule: Constitutional Implications and Practical Consequences
Digital Health

How Artificial Intelligence Manufacturers Can Protect Themselves Against Future Negligence Claims
Regulatory Updates

Five Ways FDA’s New Final Rule on Intended Use Could Affect Consumer Products
Regulatory Updates

HHS Announces Withdrawal of Good Guidance Practices and Fairness in Enforcement Rules
Regulatory Updates

U.S. Agencies Issue Regulations on No Surprises Act’s Independent Dispute Resolution Process and Good Faith Estimate Requirements
Events

Implications of FDA’s Final Rule on Intended Use on Safe-Harbored Communications
Data Privacy

Switzerland Recognizes New EU Standard Contractual Clauses and Issues Guidance on International Data Transfers
Digital Health

Pharmacovigilance Considerations in the Era of Patient Centricity: Data Collected by Apps
Events

6th Annual Bay Area Lifesciences Roundtable
Global Drug Pricing

Medicare “Most Favored Nation” Drug Payment Heading to Rescission, Shifting Focus to Potential Alternatives
Digital Health

Singapore to License Telemedicine Service Providers from 2022

Femtech in the Spotlight:
An Interview with Wolfgang Hackl, Founder and CEO of OncoGenomX

Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.

Contacts

If you have any questions regarding this issue of the Global Life Sciences Briefing or suggestions for topics to be covered in future issues, please contact the Sidley lawyer with whom you usually work, or Sidley Global Life Sciences.